Sales growth driven by continued strong performance from Kisqali (+64% cc), Entresto (+22% cc), Kesimpta (+33% cc), Scemblix (+79% cc), Leqvio (+61% cc) and Pluvicto (+30% cc) Core operating income ...

ASML’s drop post-earnings reflects short-term uncertainties, but strong service growth and market dominance signal a long-term buying opportunity. Read more on ASML here.